The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil

@article{Birkmayer2005ThePO,
  title={The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil},
  author={W. Birkmayer and P. Riederer and M. Youdim and W. Linauer},
  journal={Journal of Neural Transmission},
  year={2005},
  volume={36},
  pages={303-326}
}
  • W. Birkmayer, P. Riederer, +1 author W. Linauer
  • Published 2005
  • Psychology, Medicine
  • Journal of Neural Transmission
    • The potentiation of the ami akinetic effect after L-Dopa treatment by an inhibitor of monoamine oxidase (MAO) “B”, Deprenil, has been demonstrated in parkinsonian patients with or without previous L-Dopa therapy. Application of the drug has been performed orally, intravenously and intramuscularly. Excellent kinetic effects resulted when combined with Madopar. The combined treatment with L-Dopa was highly effective when applicated i.v. or i.m. Deprenil is an inhibitor of MAO-B and is… CONTINUE READING
    View on Springer
    ncbi.nlm.nih.gov
    146 Citations
    Highly Influential Citations
    3
    Background Citations
    53
    Methods Citations
    7
    Results Citations
    4
    146 Citations
    Citation Type

    Citation Type

    The clinical and biochemical investigation of L-deprenyl in Parkinson's disease with special reference to the “on-off” effect
    On the mode of action of L-deprenyl in the human central nervous system
    • 36
    The possible mechanisms of action of (-)deprenyl in Parkinson's disease
    • J. Knoll
    • Psychology, Medicine
    • Journal of Neural Transmission
    • 2005
    • 57
    The effect of deprenyl, a selective monoamine oxidase B inhibitor, on sleep and mood in man
    • 23
    Long term treatment with L-deprenyl
    • W. Birkmayer
    • Psychology, Medicine
    • Journal of Neural Transmission
    • 2005
    • 3
    Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm study
    • 129
    Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition
    • 36
    L-deprenyl treatment of on-off phenomena in Parkinson's disease
    • 12
    Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology
    • 102
    • PDF
    MAO-inhibitors in Parkinson's Disease
    • 140
    • PDF

    References

    SHOWING 1-10 OF 73 REFERENCES
    Die moderne medikamentöse Behandlung des Parkinsonismus
    • 11
    L-dopa level in plasma, primary condition for the kinetic effect
    • 9
    Monoamine oxidase. Its inhibition.
    • 23
    Effect of Pretreatment with Oestradiol, Progesterone and DOPA on Monoamine Oxidase Activity in the Rat
    • 77
    Biological Sciences: Human Brain Monoamine Oxidase: Multiple Forms and Selective Inhibitors
    • 122
    “On‐off” phenomenon with levodopa therapy in parkinsonism
    • 266
    Corticosteroid and growth hormone secretion in patients treated with L-dopa
    • 5
    Changes in the concentration and intracellular distribution of brain catecholamines: the effects of reserpine. beta-phenyliso-propylhydrazine, pyrogallol and 3,4-dihydroxyphenyl alanine, alone and in combination.
    • 35
    Dopamine and basal ganglia diseases.
    • 45
    Alterations in the Pattern of Amine Excretion in Man Produced by a Monoamine Oxidase Inhibitor
    • 53